RhumbLine Advisers’s Achieve Life Sciences QUIT Stock Holding History
Bought
Maintained
Sold
Other funds holding QUIT
RhumbLine Advisers's QUIT Position: Q3 2026 in Review
RhumbLine Advisers increased its Achieve Life Sciences (QUIT) stake by 3.3% in Q3 2026, buying an estimated $20.7K and bringing the position to 89,921 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.
RhumbLine Advisers first reported a position in QUIT in Q2 2013 and has held it in 10 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.
- RhumbLine Advisers held 89,921 shares of Achieve Life Sciences worth $727K as of Q3 2026.
- RhumbLine Advisers bought 2,898 Achieve Life Sciences shares in Q3 2026, an estimated $20.7K.
- Achieve Life Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2472 holding.
- RhumbLine Advisers first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 10 quarters since.
- 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.